BeiGene - 9 Year Stock Price History | ONC
Historical daily share price chart and data for BeiGene since 2016 adjusted for splits and dividends. The latest closing stock price for BeiGene as of January 03, 2025 is 180.82.
- The all-time high BeiGene stock closing price was 403.14 on September 17, 2021.
- The BeiGene 52-week high stock price is 248.16, which is 37.2% above the current share price.
- The BeiGene 52-week low stock price is 126.97, which is 29.8% below the current share price.
- The average BeiGene stock price for the last 52 weeks is 175.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| BeiGene Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
182.4100 |
184.0000 |
184.0000 |
180.8200 |
180.8200 |
-2.11% |
| 2024 |
175.0906 |
177.0000 |
246.0400 |
129.5200 |
184.7100 |
2.41% |
| 2023 |
212.0485 |
226.6300 |
274.5000 |
158.6700 |
180.3600 |
-18.00% |
| 2022 |
180.9186 |
269.5600 |
269.5600 |
121.1100 |
219.9400 |
-18.82% |
| 2021 |
331.7484 |
261.0100 |
403.1400 |
248.5600 |
270.9300 |
4.85% |
| 2020 |
207.9582 |
165.9200 |
316.6100 |
121.8400 |
258.3900 |
55.88% |
| 2019 |
140.3191 |
136.0300 |
208.3400 |
113.9900 |
165.7600 |
18.18% |
| 2018 |
153.8827 |
100.8100 |
216.7700 |
97.4100 |
140.2600 |
43.53% |
| 2017 |
60.5702 |
31.0500 |
114.7300 |
30.8100 |
97.7200 |
221.87% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$17.962B |
$2.459B |
|
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
|
